Pioglitazone, a Peroxisome Proliferator-Activated Receptor γ Agonist, Suppresses Rat Prostate Carcinogenesis

Pioglitazone, a Peroxisome Proliferator-Activated Receptor γ Agonist, Suppresses Rat Prostate Carcinogenesis

Pioglitazone (PGZ), a peroxisome proliferator-activated receptor γ agonist, which is known as a type 2 diabetes drug, inhibits cell proliferation in various cancer cell lines, including prostate carcinomas. This study focused on the effect of PGZ on prostate carcinogenesis using a transgenic rat for...

Full description

Bibliographic Details
Main Authors: Shugo Suzuki, Yukiko Mori, Aya Nagano, Aya Naiki-Ito, Hiroyuki Kato, Yuko Nagayasu, Mizuho Kobayashi, Toshiya Kuno, Satoru Takahashi
Format: Article
Language:English
Published: MDPI AG 2016-12-01
Series:International Journal of Molecular Sciences
Subjects:
peroxisome proliferator-activated receptor γ
pioglitazone
prostate
carcinogenesis
prostate cancer
nuclear factor κB
Online Access:http://www.mdpi.com/1422-0067/17/12/2071

Internet

http://www.mdpi.com/1422-0067/17/12/2071

Similar Items